ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,640Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 387

$1.42M Total Retail Price of All Prescriptions

Rank: 12 out of 387

456 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

37% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 10,986 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,006 601 S3 1 1
LISINOPRIL 533 374 2 3
PRAVASTATIN SODIUM 419 341 3 15
LEVOTHYROXINE SODIUM 365 316 4 2
FUROSEMIDE 365 283 4 7
CARVEDILOL 364 325 6 21
ZOLPIDEM TARTRATE 360 234 7 16
OMEPRAZOLE 343 243 8 4
NEXIUM 263 162 9 26
ATORVASTATIN CALCIUM 238 200 10 13
NAMENDA 218 186 11 35
CARISOPRODOL 212 42 R 12 53
GABAPENTIN 209 114 13 10
AMLODIPINE BESYLATE 203 168 14 6
CYMBALTA 203 128 14 44
ADVAIR DISKUS 203 138 14 41
WARFARIN SODIUM 192 189 17 17
POLYETHYLENE GLYCOL 3350 180 125 18 57
SIMVASTATIN 177 150 19 5
SYNTHROID 168 105 20 68
SPIRIVA 156 92 21 61
TRAMADOL HCL 152 87 22 14
CITALOPRAM HBR 152 105 22 19
HYDROCHLOROTHIAZIDE 150 101 24 12
LOSARTAN POTASSIUM 149 116 25 24
SERTRALINE HCL 147 118 26 23
DONEPEZIL HCL 139 127 27 27
POTASSIUM CHLORIDE 139 91 27 9
CYCLOBENZAPRINE HCL 123 38 R 29 42
PROAIR HFA 123 59 29 47
CARBIDOPA-LEVODOPA 122 105 31 104
LOVASTATIN 120 82 32 36
FLUTICASONE PROPIONATE 118 27 33 29
CRESTOR 117 95 34 34
PROMETHAZINE HCL 112 60 R 35 82
PREDNISONE 110 94 36 43
QUETIAPINE FUMARATE 109 71 37 88
DIGOXIN 108 97 38 40
OXYCODONE HCL-ACETAMINOPHEN 108 29 S2 38 98
PAROXETINE HCL 107 62 40 52
GLIMEPIRIDE 106 85 41 50
FENTANYL 105 84 S2 42 80
FLUOXETINE HCL 105 65 42 46
TRAZODONE HCL 102 44 44 37
METFORMIN HCL ER 100 69 45 81
TRIAMCINOLONE ACETONIDE 94 67 46 159
AMITRIPTYLINE HCL 92 64 R 47 62
SINGULAIR 91 58 48 83
METFORMIN HCL 87 73 49 8
SYMBICORT 86 49 50 196
OXYBUTYNIN CHLORIDE 85 69 51 134
LIPITOR 85 68 51 103
MELOXICAM 84 48 53 22
MORPHINE SULFATE ER 82 30 S2 54 79
RANITIDINE HCL 82 43 54 45
METOPROLOL SUCCINATE 81 59 56 18
LYRICA 80 32 57 66
AMOX TR-POTASSIUM CLAVULANATE 77 38 58 131
NAPROXEN 76 31 59 89
OXYCONTIN 75 19 S2 60 92
MONTELUKAST SODIUM 74 46 61 152
CLOPIDOGREL 73 50 62 25
LACTULOSE 71 47 63 153
PANTOPRAZOLE SODIUM 71 57 63 48
ENABLEX 66 21 65 294
PLAVIX 66 43 65 39
LEVOFLOXACIN 63 42 67 84
ZETIA 63 46 67 96
METOPROLOL TARTRATE 61 57 69 11
ALENDRONATE SODIUM 61 53 69 31
NASONEX 60 31 71 271
IBUPROFEN 58 12 72 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 31 73 30
ESCITALOPRAM OXALATE 56 23 73 73
OLANZAPINE 56 32 73 126
RISPERIDONE 55 18 76 70
OXYCODONE-ACETAMINOPHEN 51 41 S2 77 203
SUCRALFATE 51 28 77 128
EVISTA 51 46 77 111
GEMFIBROZIL 50 12 80 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.